Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials
Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials have?
Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials has 225 citations in the OpenAlex counts ScholarIQ stores.
When was Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials published?
Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials has 2013 year in the ScholarIQ index.
What is the open-access status of Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials?
Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials has closed oa status in the ScholarIQ index.
What is the DOI of Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials?
The DOI for Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials is on the source record.
What is the PMID of Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials?
The PMID for Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials is on the source record.
What is the OpenAlex record for Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials?
The OpenAlex for Blood pressure‐lowering effects of <scp>GLP</scp> ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials is on the source record.